Neuland Laboratories

About Neuland Laboratories

Neuland Labs is an exclusive API CMO with 1 Process R&D Center and 3 API manufacturing facilities with a combined reactor volume of 900,000 liters and expanding. The facilities have been inspected by USFDA 16 times (2 PAIs), EMA, PMDA and others. We are experts in Deuterated molecules, Cyanation, Solution phase peptides, Cyclic peptides, PEGylated peptides, Peptide building blocks (RSMs), Hydrogenation, Bromination, Cryogenic reactions, Cholic acid and Chenodeoxycholic acid, Enzymatic reactions. Neuland has helped American biotechs to file 8 INDs and ...

Certifications
  • US
  • 2017
    On CPHI since
  • 2
    Certificates
Company types
Manufacturer/Innovator
Contact info
Meet us at

CPHI North America 2024

Pennsylvania Convention Center, Philadelphia
07 May 2024 - 09 May 2024

Products from Neuland Laboratories (5)

  • Albuterol sulfate / salbutamol sulphate

    Product Albuterol sulfate / salbutamol sulphate

    Neuland laboratories offers wide range of products which includes albuterol sulfate / salbutamol sulphate. It belongs to bronchodilator therapeutic segment. Contact us for more information.
  • Alcaftadine

    Product Alcaftadine

    Neuland laboratories offers wide range of products which includes alcaftadine. It belongs to allergic conjunctivitis (opthalmic) therapeutic segment. Contact us for more information.
  • Apixaban

    Product Apixaban

    Neuland laboratories offers wide range of products which includes apixaban. It belongs to anticoagulant therapeutic segment. Contact us for more information.
  • Apremilast

    Product Apremilast

    Neuland laboratories offers wide range of products which includes apremilast. It belongs to psoriatic arthritis therapeutic segment. Contact us for more information.
  • Aripiprazole anhydrate

    Product Aripiprazole anhydrate

    Neuland laboratories offers wide range of products which includes aripiprazole anhydrate. It belongs to antipsychotic therapeutic segment. Contact us for more information.